Scientists have discovered significant discrepancies in PD-1 between humans and rodents, indicating that common lab models ...

Check Point (CHKP – Research Report) received a Hold rating and a $207.00 price target from Goldman Sachs analyst Gabriela Borges yesterday.

Check Point Software Technologies Ltd. (NASDAQ: CHKP), a pioneer and global leader of cyber security solutions, today announced that it has been recognized as a Leader in the 2024 Gartner ® Magic ...

HIF1α identified as key regulator that induces cancer-killing ability of hypoxic T cells, playing a role in ICB resistance.

On Friday, the FDA approved Checkpoint Therapeutics, Inc.’s (NASDAQ:CKPT) Unloxcyt (cosibelimab-ipdl) for metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are not ...

Checkpoint Therapeutics (NASDAQ:CKPT – Free Report) had its price objective hoisted by Lake Street Capital from $4.00 to $7.00 in a research note released on Monday morning,Benzinga reports. Lake ...

Additionally, Check Point Research has reported a significant 75% increase in worldwide cyber-attacks in the third quarter of 2024. These concerning figures highlight the critical importance of ...

By narrowing their research to overweight and obese individuals, Roswell Park researchers found that metformin might offer ...

Among the most profound results presented at the 2024 European Society for Medical Oncology Congress were the 10-year data ...

Check Point Software Technologies (NASDAQ:CHKP – Get Free Report) had its target price increased by research analysts at ...